U.S., Sept. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07175662) titled 'Evaluation of NWRD08 for HPV-16 and/or HPV-18 Related Cervical HSIL' on Sept. 01.
Brief Summary: This is a randomized, double-blind, placebo controlled Phase 2 study to determine the efficacy and safety of NWRD08 administered by intramuscular (IM) injection followed by electroporation (EP) in adult women with histologically confirmed cervical high grade squamous intraepithelial lesion (HSIL) (cervical intraepithelial neoplasia grade 2 [CIN2] or grade 3 [CIN3]) associated with human papillomavirus (HPV) 16 and/or HPV18.
Study Start Date: Oct. 10
Study Type: INTERVENTIONAL
Condition:
High-grade Squamous Intraepithelial Lesion (HS...